686 studies found for:    Open Studies | "Bone Marrow Diseases"
Show Display Options
Rank Status Study
21 Recruiting A Study Comparing Ponatinib and Nilotinib in Patients With Chronic Myeloid Leukemia
Condition: Chronic Phase Chronic Myeloid Leukemia
Interventions: Drug: ponatinib 30 mg QD;   Drug: ponatinib 15 mg QD;   Drug: nilotinib 400 mg BID
22 Recruiting Ponatinib in Patients With Resistant Chronic Phase Chronic Myeloid Leukemia (CML) to Characterize the Efficacy and Safety of a Range of Doses
Condition: Myeloid Leukemia, Chronic, Chronic Phase
Interventions: Drug: ponatinib 45 mg;   Drug: ponatinib 30 mg;   Drug: ponatinib 15 mg
23 Recruiting Sertraline in Treatment of Low-Risk Myelodysplastic Syndrome
Condition: Myelodysplastic Syndromes
Interventions: Drug: Sertraline;   Procedure: Bone Marrow Aspirate/Biopsy
24 Recruiting Safety and Tolerability Study of Oral NS-018 in Patients With Primary Myelofibrosis (MF), Post-polycythemia Vera MF or Post-essential Thrombocythemia MF
Conditions: Primary Myelofibrosis;   Post-Polycythemia Vera Myelofibrosis;   Post-Essential Thrombocythemia Myelofibrosis
Intervention: Drug: NS-018
25 Available Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant
Conditions: Acute Lymphoblastic Leukemia;   Acute Myeloid Leukemia;   Chronic Myeloid Leukemia;   Myelodysplastic Syndrome;   Lymphomas;   Bone Marrow Failure;   Hemoglobinopathy;   Immune Deficiency;   Osteopetrosis;   Cytopenias;   Leukocyte Disorders;   Anemia Due to Intrinsic Red Cell Abnormality
Intervention: Biological: CD34+ enriched, T Cell Depleted donor stem cell product
26 Unknown  Bortezomib and Low Dose Cytarabine in the Treatment of High-Risk Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Intervention: Drug: Bortezomib
27 Recruiting Raltegravir for HAM/TSP
Condition: HTLV-I Infection
Intervention: Drug: Raltegravir
28 Not yet recruiting Dose-finding, Safety and Efficacy Study of Radium-223 Dichloride (XOFIGO) in RCC Patients With Bone Metastases. (EIFFEL)
Conditions: Clear-cell Metastatic Renal Cell Carcinoma;   Bone Metastases
Intervention: Drug: XOFIGO
29 Recruiting Evaluation of Sodium Fluoride PET in the Identification of Bone Metastases in Patients Having Undergone a Choline PET for Occult Recurrence of Prostatic Adenocarcinoma
Condition: Bone Metastasis
Intervention: Procedure: Sodium fluoride PET
30 Not yet recruiting Investigating the Safety, Tolerability and Efficacy of Amorphous Calcium Carbonate (ACC) on the Treatment of Subjects With CRPC
Condition: Castrate Resistant Prostate Cancer With Bone Metastasis
Interventions: Drug: Amorphous calcium carbonate;   Other: Placebo
31 Recruiting Evaluation of Medical Practice in the Management of Bone Metastases After Injectable Bone Antiresorptive Treatment, and Its Influence on Quality of Life
Condition: Tumor With Bone Metastasis
Interventions: Other: quality of life questionaries;   Drug: intravenous or oral bone antiresorptive treatments
32 Recruiting Preliminary Evaluation of Uptake in Bone Metastases and Biodistribution of [68Ga]P15-041
Conditions: Prostate Cancer;   Bone Metastases
Intervention: Drug: [68Ga]P15-041
33 Recruiting Association of Bone and Metabolic Parameters With Overall Survival in Patients With Bone Metastases From Adenocarcinoma Lung Cancer (POUMOS)
Conditions: Bone Metastases;   Lung Cancer
Intervention: Other: Bone metastases biopsy
34 Recruiting Efficacy of Radiotherapy in Combination With Zoledronic Acid in Bone Metastasis Patients With Gastrointestinal Tumors
Conditions: Bone Metastasis;   Gastrointestinal Cancer
Interventions: Drug: Zoledronic acid;   Radiation: Radiotherapy
35 Recruiting A Study to Collect Data About Analgesia in Patients With Bone Metastasis
Condition: Bone Metastasis
Interventions: Other: Questionnaires completion;   Other: Clinical Pain Assessments
36 Recruiting The OPTIMAL Study - A Prospective Cohort of Patients With Bone Metastases of the Long Bones
Condition: Bone Metastasis
Interventions: Procedure: Stabilisation of (impending) pathological fracture;   Radiation: Radiotherapy of bone metastasis
37 Recruiting Palliative Radiation Therapy in Reducing Pain in Patients With Bone Metastasis
Conditions: Malignant Neoplasm;   Metastatic Malignant Neoplasm in the Bone;   Pain
Interventions: Radiation: External Beam Radiation Therapy;   Radiation: Palliative Radiation Therapy;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration
38 Not yet recruiting Safety and Efficacy of DC-CIK in Patients With Advanced Non-Small-Cell Lung Cancer With Bone Metastases
Condition: Non-Small-Cell Lung Cancer With Bone Metastases
Intervention: Biological: genetically modified dendritic cells + cytokine-induced killer
39 Recruiting Androgen Deprivation Therapy +/- Radium-223 Dichloride in Metastatic Prostate Cancer With Bone Metastases
Conditions: Prostate Cancer;   Bone Metastases;   Prostate Neoplasms
Interventions: Drug: LHRH agonist/antagonist;   Drug: Bicalutamide;   Radiation: Radium-223 dichloride
40 Recruiting Vaccine Therapy and Pembrolizumab in Treating Patients With Hormone-Resistant, Metastatic Prostate Cancer
Conditions: Hormone-Resistant Prostate Cancer;   Metastatic Malignant Neoplasm in the Bone;   Metastatic Malignant Neoplasm in the Soft Tissues;   Metastatic Prostate Carcinoma;   Prostate Adenocarcinoma;   Recurrent Prostate Carcinoma;   Stage IV Prostate Cancer
Interventions: Biological: Pembrolizumab;   Biological: pTVG-HP Plasmid DNA Vaccine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years